Skip to main content
Uncategorized

Annual Conference of Biomedical Research Platforms

By 5 de March de 2014November 18th, 2020No Comments
< Back to news
Photo: Institute for Bioengineering of Catalonia (IBEC).
 05.03.2014

Annual Conference of Biomedical Research Platforms

Under the title 'The challenge of health', Barcelona hosted on 4th and 5th of March. the 7th Annual Conference of the Biomedical Research Technology Platforms: Innovative Medicines, Nanomedicine, Health Technology and Biotechnology Markets, organised by Farmaindustria, ASEBIO, FENIN and the IMIM Hospital del Mar Medical Research Institute (IMIM). The conference brings together more than 200 scientists and researchers in the field of biomedicine, and unveils new nationally and international initiatives and projects to promote collaboration between public and private bodies under the different biomedical research platforms. As coordinator of the Spanish Nanomedicine Platform (NanoMedSpain), the IBEC –based in the PCB– was co-organizer of this event.


Yesterday director Josep Samitier presented NanoMed Spain and gave a roundup of its activities during the past year, and later took part in a press conference alongside the coordinators of the other three biomedical research platforms that take part in the event: Innovative Medicines, Health Technology, and Biotechnology.

Josep highlighted that NanoMed Spain now has 138 members, including 37 companies, and worked hard during 2013 to promote inter-platform collaborations, establishing of a cross-platform nanosafety group which was presented at December’s Jornada Anual del Grupo Inter-Plataformas de Nanoseguridad y Nanotoxicología. It is also very active as advisor to the political programme of the EC regarding the clinical translation of nanomedicine via its involvement in such initiatives as the NANOMED2020 Support Action project, “Enabling the European Nanomedicine Area until 2020”. Josep also outlined a new initiative under discussion with the European Technological Platform to launch the EU-NCL, a European Nano-Characterisation Laboratory to mirror the US National Cancer Institute.

More generally, Josep also talked about the importance of the government’s efforts to keep scientific funding opportunities going. “We need a firm, long-term commitment to the sector to make sure that our country, envied up until now for its science, does not become a pitied country,” he said. He stressed that Spain was the leading country in Europe for nanomedicine publications in the period 2005-2014 and fourth in the world behind USA, China and the recently advanced India.

For further information [+]